FR Doc E8-18064[Federal Register: August 6, 2008 (Volume 73,
Number 152)] [Notices] [Page 45781] From the Federal Register
Online via GPO Access [wais.access.gpo.gov] [DOCID:fr06au08-87]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances; Notice of Registration
By Notice dated March 10, 2008 and published in the Federal
Register on March 19, 2008, (73 FR 14839), Roche Diagnostics
Operations, Inc., Attn: Regulatory Compliance, 9115 Hague Road,
Indianapolis, Indiana 46250, made application by renewal to the
Drug Enforcement Administration (DEA) to be registered as an
importer of the basic classes of controlled substances listed in
schedules I and II:
|
Drug
|
Schedule
|
|
Lysergic acid diethylamide (7315)
|
I
|
|
Alphamethadol (9605)
|
I
|
|
Tetrahydrocannabinols (7370)
|
I
|
|
Cocaine (9041)
|
II
|
|
Ecgonine (9180)
|
II
|
|
Methadone (9250)
|
II
|
|
Morphine (9300)
|
II
|
The company plans to import the listed controlled substances
for the manufacture of diagnostic products for distribution to
its customers.
No comments or objections have been received. DEA has
considered the factors in 21
U.S.C. 823(a) and 952(a) and
determined that the registration of Roche Diagnostics
Operations, Inc. to import the basic classes of controlled
substances is consistent with the public interest, and with
United States obligations under international treaties,
conventions, or protocols in effect on May 1, 1971, at this
time. DEA has investigated Roche Diagnostics Operations, Inc. to
ensure that the company's registration is consistent with the
public interest. The investigation has included inspection and
testing of the company's physical security systems, verification
of the company's compliance with state and local laws, and a
review of the company's background and history. Therefore,
pursuant to 21 U.S.C. 952(a) and Sec.
958(a), and in accordance
with 21 CFR
1301.34, the above named company is granted
registration as an importer of the basic classes of controlled
substances listed.
Dated: July 30, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement Administration.
[FR Doc. E8-18064 Filed 8-5-08; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an
unofficial version. An official version of these publications may be obtained
directly from the Government Printing Office (GPO).
